Blog

Health Spotlight | Good cholesterol bad for glaucoma?

High HDL Cholesterol May Increase Glaucoma Risk: New Study Reveals For years, high-density lipoprotein (HDL) cholesterol has been celebrated as the “good cholesterol” due to its role in protecting heart health. However, a groundbreaking new study suggests that elevated HDL levels might be linked to an increased risk of glaucoma—a leading cause of irreversible blindness. […]

Health Spotlight | Good cholesterol bad for glaucoma? Read More »

glaucoma-eye-problem

Vitamin Supplements Could Slow Glaucoma Progression

Vitamin Supplements May Slow Glaucoma Progression, Study Finds Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While treatments like eye drops, laser therapy, and surgery aim to lower intraocular pressure (IOP), researchers are constantly exploring new ways to slow disease progression. A recent study suggests that vitamin supplements could play

Vitamin Supplements Could Slow Glaucoma Progression Read More »

glaucoma-eye-problem

PER-001 Glaucoma Implant Shows Positive Trial Results

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant breakthrough for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for PER-001, a novel implant designed to manage intraocular pressure (IOP) in glaucoma patients. The study demonstrated both safety and efficacy, marking a promising step

PER-001 Glaucoma Implant Shows Positive Trial Results Read More »

glaucoma-eye-problem

Fluorescein Angiography Insights by Dr. Alan J. Franklin

How Intraoperative Fluorescein Angiography Enhances RWC 2025 Surgical Outcomes In the rapidly evolving field of surgical medicine, advancements in imaging technologies are revolutionizing patient outcomes. One such breakthrough is intraoperative fluorescein angiography (IFA), a real-time imaging technique that is transforming surgical precision, particularly in complex procedures like those anticipated in the RWC 2025 (Robotic and

Fluorescein Angiography Insights by Dr. Alan J. Franklin Read More »

glaucoma-eye-problem

Minimally Invasive Glaucoma Treatments in Development

Minimally Invasive Glaucoma Treatments Show Promising Advances Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Traditional treatments like eye drops, laser therapy, and invasive surgeries have been the mainstay for decades. However, recent advancements in minimally invasive glaucoma treatments (MIGS) are revolutionizing how this condition is managed.

Minimally Invasive Glaucoma Treatments in Development Read More »

glaucoma-eye-problem

BrightFocus Awards $13M for Glaucoma Research

BrightFocus Foundation Awards $13M for Alzheimer’s and Eye Disease Research In a groundbreaking move to advance medical research, the BrightFocus Foundation has announced the allocation of $13 million in grants to support cutting-edge studies on Alzheimer’s disease and eye diseases. This significant investment underscores the foundation’s commitment to accelerating breakthroughs in neurodegenerative and vision-related conditions,

BrightFocus Awards $13M for Glaucoma Research Read More »

glaucoma-eye-problem

Advances in Nonimplant MIGS for Glaucoma Treatment

Top Advances in Nonimplant MIGS for Glaucoma Treatment Glaucoma, a leading cause of irreversible blindness worldwide, has seen significant advancements in treatment options over the past decade. Among these, Minimally Invasive Glaucoma Surgery (MIGS) has emerged as a game-changer, offering safer and less invasive alternatives to traditional surgeries. While implant-based MIGS devices have gained attention,

Advances in Nonimplant MIGS for Glaucoma Treatment Read More »

glaucoma-eye-problem

Dr. Dilsher Dhoot on HELIOS Diabetic Retinopathy Trial

HELIOS Trial Insights: Dr. Dilsher S. Dhoot on Diabetic Retinopathy Breakthroughs Diabetic retinopathy (DR) remains one of the most common and devastating complications of diabetes, affecting millions worldwide. The HELIOS trial has emerged as a groundbreaking study, offering new hope for patients battling this vision-threatening condition. In this article, we delve into the key insights

Dr. Dilsher Dhoot on HELIOS Diabetic Retinopathy Trial Read More »

Can good cholesterol actually be bad for glaucoma?

Can High HDL Cholesterol Worsen Glaucoma Risk? Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While high intraocular pressure (IOP) is a well-known risk factor, emerging research suggests that cholesterol levels—particularly high-density lipoprotein (HDL) cholesterol—may also play a role. But could high HDL cholesterol actually worsen glaucoma risk? Let’s explore

Can good cholesterol actually be bad for glaucoma? Read More »

Scroll to Top